Ticker LaunchRegulation A · Tier 2
Quadrant Biosciences Inc
Quadrant Biosciences Inc filed a Tier 2 Regulation A offering statement (Form 1-A) on Feb 14, 2020 for up to $15M at $3.00 per security. The SEC qualified the offering on Mar 9, 2020. Underwriter or broker: N, o and r.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $15M
- Offer price
- $3.00
- Security type
- Equity (common or preferred stock)
- Filed
- Feb 14, 2020
- Qualified
- Mar 9, 2020
- Industry
- Pharmaceutical Preparations
- State
- NY
- Underwriter / broker
- N, o, r, t, h, C, a, p, i, l, P, v, e, S, c, u, s and n
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Feb 14, 2020
- Final offering circular (253G2)
- All filings on EDGAR CIK 1651239
Other qualified Biotech & pharma Reg A offerings
- Cytonics CorpJul 6, 2020 · $19M
- Bioquest CorpMay 22, 2020 · $1M
- Verax Research Services, Inc.May 4, 2020 · $50M
- Mystic Holdings Inc./NVMar 20, 2020 · $50M
- CBD Life Sciences Inc.Mar 11, 2020 · $2M
- Scopus BioPharma Inc.Feb 4, 2020 · $1M